Lincoln National Corp’s Genelux GNLX Stock Holding History

Lincoln National Corp’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-61,015	Closed	-$392K	–	464
2024 Q1	$392K	Buy	+61,015	New	+$554K	0.01%	843

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Lincoln National Corp's GNLX Position: Q2 2024 in Review

Lincoln National Corp sold out of Genelux (GNLX) in Q2 2024, closing a stake of 61,015 shares — an estimated $392K sold.

Lincoln National Corp first reported a position in GNLX in Q1 2024 and held it in 1 quarter. The position peaked at $392K in Q1 2024. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2024.

Lincoln National Corp reported no remaining Genelux position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 61,015 Genelux shares in Q2 2024, an estimated $392K.
Lincoln National Corp first reported a position in Genelux in Q1 2024 and held it in 1 quarter.
Lincoln National Corp's Genelux position peaked at $392K in Q1 2024.
73 funds tracked by Wall St. Rank held Genelux as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.